Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 04/25/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11674 publications
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 15, 2025
Remote presentation of nivolumab-induced bullous pemphigoid in hepatocellular carcinoma.
Journal: BMJ case reports
Published: April 08, 2025
Letter to the Editor Re: Research Progress and Efficacy Evaluation of Nivolumab in the Treatment of Metastatic Renal Cancer.
Journal: Archivos espanoles de urologia
Published: April 07, 2025
DNA Mismatch Repair Deficiency as a Biomarker in Sarcoma.
Journal: Surgical oncology insight
Published: April 07, 2025
A Case of Advanced Gastric Cancer in Which Complete Pathological Response to Pre-Operative SOX and Nivolumab Therapy Was Noted Despite Severe Liver Dysfunction
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 07, 2025
Clinicopathologic Characteristics of Immune Checkpoint Inhibitor-related Pancreatitis.
Journal: The American journal of surgical pathology
Published: April 07, 2025
A Case of Stage Ⅳ Gastric Cancer with Distant Metastasis That Underwent Curative Surgery and Achieved Complete Response in Primary Lesion after Systemic Chemotherapy with Nivolumab
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 07, 2025
Association of Sex with Survival and Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Experience in Türkiye.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: April 01, 2025
CLO25-069: Single Dose Nivolumab and Ipilimumab Treatment Causing Complete and Durable Response in Extensive Stage Small Cell Lung Cancer Complicated By Severe Sensory Autoimmune Neuropathy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE).
Journal: Future oncology (London, England)
Published: March 28, 2025
Last Updated: 04/25/2025